Paclitaxel-Coated Balloon Plus Bailout Stenting vs Planned DES Implantation for De Novo Coronary Lesions: 3-Year Outcomes of the REC-CAGEFREE I Trial
The REC-CAGEFREE I trial demonstrated that among patients undergoing non-complex PCI for de novo coronary lesions, treatment with the Swide paclitaxel-coated balloon (PCB) plus bailout stenting resulted in a significantly higher 3-year rate of device-oriented clinical events (DoCE) compared with planned DES implantation, according to a study presented by Dr. Chao Gao, Xijing Hospital, China, in the Late-Breaking Clinical Science session at TCT 2025.
- Free Registration
-
Already have an account?Log In
A portal site of complex catheter intervention techniques
TCROSS NEWS Global is an online medical journal that provides
valuable information on Cardiovascular medicine to medical professionals
worldwide.
We bring you the latest findings and trends in all areas of
cardiovascular medicine. Please register and subscribe for unlimited access to
quality Cardiovascular News!
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
